Staff members put on protective suits before entering the laboratory of KingMed Diagnostics, a Chinese medical diagnostic testing company in Beijing, capital of China, late June 25, 2020. With 2,422 sample collection points set up at 480 venues across the capital, Beijing can now offer more than 300,000 nucleic acid tests for COVID-19 every day. (Xinhua/Ju Huanzong)